The overarching goal of Dr. Wainford’s translational research program is to drive the development of clinically relevant mechanism-based approaches for the detection, prevention, and treatment of hypertension, the SSBP and hypertension-driven cognitive impairment across the lifespan. Hypertension, the prevalence of which increases with age, affects approximately 1 in 2 U.S. adults, is the leading global non-communicable cause of mortality, and is an independent modifiable risk factor for cognitive impairment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Mid Level
Education Level
No Education Listed
Number of Employees
5,001-10,000 employees